The National Ketamine Shortage Grinds On Causing Major Disruptions

All across the nation ketamine is on backorder Due to a staggering increase in demand for ketamine, there is a national shortage of this drug that is affecting thousands of clinics, hospitals, and providers. The major pharmaceutical companies that manufacture ketamine, Hikma Pharmaceuticals, Hospira, Pfizer, Mylan Institutional, and Par Pharmaceutical, continue to push back their …

Nasal Ketamine is Here: Spravato and the Controversy

On March 5th, 2019, the U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray. The approval is for Spravato to be used in conjunction with an oral antidepressant for the treatment of depression in adults who have failed to benefit from oral antidepressant medications. Doctors must order medication for a particular patient and pick …

Leading the Way in Ketamine Therapy in New Mexico: Klarisana in Carlsbad

The most caring ketamine clinic in southeastern New Mexico Treating depression is downright challenging. Both selective serotonin reuptake inhibitors (SSRIs) and serotonin- and noradrenaline reuptake inhibitors (SNRIs) are widely prescribed for the treatment of major depression. While the large majority of individuals (~70%) with depression exhibit at least some improvement with antidepressant medication, approximately 30% …

Ketamine in the Treatment of Suicidal Behaviors

Published in: Int J Mol Sci. 2018 Sep 23;19(10). pii: E2888. doi: 10.3390/ijms19102888. Ketamine may decrease suicidal thoughts The mechanism of action of ketamine in the treatment of suicidal patients involves several pathways but, first of all, the glutamatergic system seems to play a pivotal role. In fact, it has been suggested that a glutamate …

Verbal Learning and Speed of Mental Processing Improved After Ketamine Treatment

Research shows that depression successfully treated with ketamine helps learning J Psychopharmacol. 2018 Oct;32(10):1118-1126. doi: 10.1177/0269881118798614. Epub 2018 Sep 27. Summary Ketamine has proven to have rapid, robust antidepressant effects on treatment-resistant depression. However, whether repeated ketamine infusions would cause short-and long-term neurocognitive impairments was not clear. Our aims were to investigate the neurocognitive effects …

12